Mood Disorders Center of Ottawa

The Mood Disorders Center of Ottawa (MDCO) is a specialized clinical and research facility based in Ottawa, Canada, dedicated to the diagnosis, treatment, and long-term management of mood disorders. Directed by Dr. Paul Grof, the center is a prominent site for psychiatric research, particularly in the areas of lithium response, psychiatric genetics, and the longitudinal tracking of bipolar disorder. MDCO participates in international research consortia such as ConLiGen and has served as a sponsor and site for clinical trials evaluating therapies like quetiapine. The center provides expert psychiatric care and contributes significantly to the global understanding of affective disorders through its extensive academic and clinical collaborations.